Zymeworks (ZYME) Change in Receivables (2021 - 2026)

Zymeworks (ZYME) has 6 years of Change in Receivables data on file, last reported at $36000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables rose 100.12% year-over-year to $36000.0; the trailing twelve-month figure through Mar 2026 stood at -$19.9 million (down 215.19% YoY), and the FY2025 full-year result was -$51.2 million, down 240.82% from the prior year.
• Change in Receivables advanced to $36000.0 in Q1 2026, from -$24.7 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $33.5 million in Q1 2023 to a low of -$47.8 million in Q4 2023.
• A 5-year average of -$659882.4 and a median of $36000.0 in 2026 frame the typical range for Change in Receivables.
• Peak annual rise in Change in Receivables reached 697.92% in 2023, while the deepest fall reached 11886.09% in 2023.
• Tracing ZYME's Change in Receivables over 5 years: stood at $26.7 million in 2022, then tumbled by 279.2% to -$47.8 million in 2023, then soared by 166.18% to $31.6 million in 2024, then sank by 178.13% to -$24.7 million in 2025, then soared by 100.15% to $36000.0 in 2026.
• Business Quant data shows ZYME's Change in Receivables at $36000.0 in Q1 2026, -$24.7 million in Q4 2025, and $26.7 million in Q3 2025.